Insulin resistance and coronary artery disease.

  title={Insulin resistance and coronary artery disease.},
  author={Maheswari Chenniappan},
  journal={Journal of the Indian Medical Association},
  volume={105 1},
          29-32, 36
A large body of clinical evidence supports aggressive cardiovascular risk management in combination with glycaemic control in patients with type 2 diabetes and insulin resistance. Glycaemic management in a patient with HbA1c that is at or near goal should include an assessment of postprandial glycaemia. Insulin sensitisers have glycaemic and non-glycaemic benefits and warrant consideration even if the HbA1c is not significantly elevated. Oral agents should always be combined with lifestyle… CONTINUE READING